Kamada (KMDA) Asset Utilization Ratio (2013 - 2026)
Kamada's (KMDA) quarterly Asset Utilization Ratio came in at 117.87 in Q1 2026, up 3.4% YoY from 113.99 in Q1 2025, and down 0.76% on a QoQ basis from 118.77 in Q4 2025.
Kamada (KMDA) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Kamada (KMDA) has 11 years of Asset Utilization Ratio data on file, last reported at 117.87 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 3.4% year-over-year to 117.87 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 117.87 (up 3.4% YoY) and the FY2025 annual result came in at 0.48, up 8.57% from the prior year.
- Asset Utilization Ratio declined to 117.87 in Q1 2026, from 118.77 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 121.29 in Q3 2024 to a low of 0.0 in Q1 2024.
- A 5-year average of 49.02 and a median of 0.4 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio plunged 99.78% — and 2025, when it soared 13092868.96%.
- Tracing KMDA's Asset Utilization Ratio over 5 years: stood at 0.2 in 2022, then dropped by 9.55% to 0.18 in 2023, then jumped by 64346.1% to 117.74 in 2024, then gained by 0.87% to 118.77 in 2025, then dropped by 0.76% to 117.87 in 2026.
- The last three Asset Utilization Ratio figures came in at 117.87 (Q1 2026), 118.77 (Q4 2025), and 120.43 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Kamada | 462.32 Mn | 432.85 Mn | 22.47 Mn | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.50 |
| Mar 31, 2026 | 117.87 |
| Dec 31, 2025 | 118.77 |
| Sep 30, 2025 | 120.43 |
| Jun 30, 2025 | 120.76 |
| Mar 31, 2025 | 113.99 |
| Dec 31, 2024 | 117.74 |
| Sep 30, 2024 | 121.29 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.18 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.40 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.20 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.35 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.48 |